PL2359816T3 - Formulacje aripiprazolu - Google Patents

Formulacje aripiprazolu

Info

Publication number
PL2359816T3
PL2359816T3 PL11153639T PL11153639T PL2359816T3 PL 2359816 T3 PL2359816 T3 PL 2359816T3 PL 11153639 T PL11153639 T PL 11153639T PL 11153639 T PL11153639 T PL 11153639T PL 2359816 T3 PL2359816 T3 PL 2359816T3
Authority
PL
Poland
Prior art keywords
aripiprazole formulations
aripiprazole
formulations
Prior art date
Application number
PL11153639T
Other languages
English (en)
Inventor
Ahmet Toksöz
Ümit Cifter
Ali Türkyilmaz
Nur Pehlivan Akalin
Vildan Demir
Burcu Mesut
Original Assignee
Arven Ilac Sanayi Ve Ticaret A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arven Ilac Sanayi Ve Ticaret A.S. filed Critical Arven Ilac Sanayi Ve Ticaret A.S.
Publication of PL2359816T3 publication Critical patent/PL2359816T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL11153639T 2010-02-09 2011-02-08 Formulacje aripiprazolu PL2359816T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2010/00948A TR201000948A1 (tr) 2010-02-09 2010-02-09 Aripiprazol formülasyonları.
EP11153639.7A EP2359816B1 (en) 2010-02-09 2011-02-08 Aripiprazole formulations

Publications (1)

Publication Number Publication Date
PL2359816T3 true PL2359816T3 (pl) 2017-04-28

Family

ID=42551366

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11153639T PL2359816T3 (pl) 2010-02-09 2011-02-08 Formulacje aripiprazolu

Country Status (4)

Country Link
EP (1) EP2359816B1 (pl)
ES (1) ES2607440T3 (pl)
PL (1) PL2359816T3 (pl)
TR (1) TR201000948A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3753B1 (ar) 2011-10-14 2021-01-31 Otsuka Pharma Co Ltd قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه
WO2013100878A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Pharmaceutical formulations comprising aripiprazole
WO2014104989A1 (en) * 2011-12-27 2014-07-03 Mahmut Bilgic Pharmaceutical compositions comprising aripiprazole
WO2013175508A2 (en) 2012-05-24 2013-11-28 Medreich Limited Stable pharmaceutical composition of aripiprazole
EP3065700A1 (en) * 2013-11-07 2016-09-14 Synthon B.V. Orodispersible pharmaceutical compositions comprising aripiprazole

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
WO2003030868A1 (en) * 2001-10-09 2003-04-17 Bristol-Myers Squibb Company Flashmelt oral dosage formulation
MY129350A (en) 2001-04-25 2007-03-30 Bristol Myers Squibb Co Aripiprazole oral solution
JP4310605B2 (ja) 2001-05-25 2009-08-12 大塚製薬株式会社 医薬用組成物
EP1797039A1 (en) 2004-09-13 2007-06-20 Matrix Laboratories Ltd Process for the preparation of polymorphs, solvates of aripiprazole using aripiprazole acid salts
CN101111481A (zh) 2004-11-18 2008-01-23 斯索恩有限公司 制备结晶阿立哌唑的方法
WO2006097344A1 (en) * 2005-03-17 2006-09-21 Synthon B.V. Pharmaceutical tablets of crystalline type ii aripiprazole
CA2614526A1 (en) * 2005-07-11 2006-10-12 Nycomed Danmark Aps Benzimidazole formulation
WO2007035348A2 (en) * 2005-09-15 2007-03-29 Elan Pharma International, Limited Nanoparticulate aripiprazole formulations
ES2325219T3 (es) * 2006-01-05 2009-08-28 Teva Pharmaceutical Industries Ltd Formulaciones secas de aripiprazol.
WO2007113846A1 (en) 2006-04-03 2007-10-11 Alembic Limited A process for the preparation of aripiprazole
EP1880714A1 (en) 2006-07-20 2008-01-23 Helm AG Amorphous Aripiprazole and Process for the Preparation thereof
TR200604349A2 (tr) * 2006-08-15 2008-03-21 NOBEL İLAÇ SANAYii VE TiCARET A.Ş. Aripiprazol içeren farmasötik bileşimler
ES2353444T3 (es) * 2008-01-23 2011-03-02 Helm Ag Aripiprazol amorfo y procedimiento para su preparación.
WO2010079506A2 (en) * 2008-06-23 2010-07-15 Torrent Pharmaceuticals Ltd. Pharmaceutical composition of aripiprazole

Also Published As

Publication number Publication date
EP2359816A1 (en) 2011-08-24
ES2607440T3 (es) 2017-03-31
TR201000948A1 (tr) 2011-08-22
EP2359816B1 (en) 2016-09-21

Similar Documents

Publication Publication Date Title
IL223206A0 (en) Vaccine formulations
PL2359816T3 (pl) Formulacje aripiprazolu
SG10201602111VA (en) Formulations Comprising Methylthioninium Chloride
ZA201300194B (en) Formulations
GB201110193D0 (en) Formulations
GB201013513D0 (en) Formulations
PL2908859T3 (pl) Formulacje arypiprazolu
GB201110278D0 (en) Formulations
TWM400834U (en) Otoscopes
ZA201300196B (en) Formulations
GB201006326D0 (en) Formulation
GB201018649D0 (en) Formulations
GB201018647D0 (en) Formulations
GB201018645D0 (en) Formulations
GB201018648D0 (en) Formulations
GB201012589D0 (en) Formulations
GB201010494D0 (en) Formulations
GB201008470D0 (en) Formulations
GB201008358D0 (en) Formulations
GB201007959D0 (en) Formulations
GB201007702D0 (en) Formulations
GB201005587D0 (en) Novel formulations
GB201005992D0 (en) Formulation
GB201001978D0 (en) Formulation
GB201002000D0 (en) Formulation